The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells

被引:12
作者
Coe, David [1 ]
Addey, Caroline [1 ]
White, Matthew [1 ]
Simpson, Elizabeth [2 ]
Dyson, Julian [2 ]
Chai, Jian-Guo [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Canc Immunotherapy Grp, Immunobiol Sect, Dept Med, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, T Cell Dev Grp, Immunobiol Sect, Dept Med, London W12 0NN, England
基金
英国生物技术与生命科学研究理事会;
关键词
adoptive transfer; Foxp3; immune evasion; regulatory T cells; tumour; DRAINING LYMPH-NODES; DENDRITIC CELLS; IMMUNITY; TOLERANCE; TRANSPLANTATION; AUTOIMMUNITY; SUPPRESSION; EXPRESSION; INDUCTION; CANCER;
D O I
10.1111/j.1365-2567.2010.03328.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study we investigated the impact of several factors on the expansion of natural regulatory T (nTreg) cells by tumours, including antigen specificity, transforming growth factor-beta (TGF-beta) signalling and the antigen-presenting cell subsets responsible for expansion. We found that antigen non-specific expansion of nTreg cells is tumour cell line-dependent. Although both antigen-specific and non-specific pathways can contribute to expansion, the migration of activated nTreg cells to tumour tissues is strictly antigen-dependent. Intact TGF-beta signalling on nTreg cells is also essential for tumour-induced expansion. Finally, for stimulation of resting antigen-specific CD4 T cells, CD11c(+) cells purified from tumour-draining lymph nodes were more potent than CD11b(+) cells, suggesting that dendritic cells are the key antigen-presenting cell subset involved in cross-presentation of tumour antigens. This study not only provides an in vivo system in which cross-talk between nTreg cells and tumours can be explored but also reveals novel aspects of tumour immune evasion.
引用
收藏
页码:556 / 569
页数:14
相关论文
共 27 条
[21]  
SUMMERHAYES IC, 1979, JNCI-J NATL CANCER I, V62, P1017
[22]   Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells [J].
Turk, MJ ;
Guevara-Patiño, JA ;
Rizzuto, GA ;
Engelhorn, ME ;
Houghton, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :771-782
[23]   Modulation of protective T cell immunity by complement inhibitor expression on tumor cells [J].
Varela, Juan C. ;
Imai, Masaki ;
Atkinson, Carl ;
Ohta, Rieko ;
Rapisardo, Michelle ;
Tomlinson, Stephen .
CANCER RESEARCH, 2008, 68 (16) :6734-6742
[24]   Induction of antigen-specific regulatory T cells in wild-type mice: Visualization and targets of suppression [J].
Verginis, Panayotis ;
McLaughlin, Katherine A. ;
Wucherpfennig, Kai W. ;
von Boehmer, Harald ;
Apostolou, Irina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (09) :3479-3484
[25]   Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines [J].
Zhou, G ;
Drake, CG ;
Levitsky, HI .
BLOOD, 2006, 107 (02) :628-636
[26]   Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance [J].
Zhou, Gang ;
Levitsky, Hyam I. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (04) :2155-2162
[27]   Regulatory T cells, tumour immunity and immunotherapy [J].
Zou, WP .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (04) :295-307